Back
Aclaris Therapeutics Stock Price Chart
Sponsored
ACRS
Sponsored
BREAKING: Elon Musk's Secret A.I. Project Set to Plunge Millions of Americans Into Poverty
Click here now to prepare yourself for what's around the corner
Sell
11
ACRS
Aclaris Therapeutics
Last Price:
1.22
Seasonality Move:
4.39%
7 Day Trial
ALL ACCESS PASS
$
7
7 Powerhouse Stocks to Buy and Hold Forever
Get it now.- The current trend is relatively stagnant and ACRS is experiencing buying pressure, which is a positive indicator for future bullish movement.
Aclaris Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.21 | Buy |
20-day SMA: | 1.21 | Buy |
50-day SMA: | 1.22 | Sell |
200-day SMA: | 3.72 | Sell |
8-day EMA: | 1.21 | Buy |
20-day EMA: | 1.21 | Buy |
50-day EMA: | 1.25 | Sell |
200-day EMA: | 3.6 | Sell |
Aclaris Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 51.41 | Buy |
Chaikin Money Flow: | 633433 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.18 - 1.24) | Buy |
Bollinger Bands (100): | (1.07 - 1.27) | Buy |
Aclaris Therapeutics Technical Analysis
Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Aclaris Therapeutics Stock
Is Aclaris Therapeutics Stock a Buy?
- Aclaris Therapeutics share price is 1.22 while ACRS 8-day simple moving average is 1.21, which is a Buy signal.
- The stock price of ACRS is 1.22 while Aclaris Therapeutics 20-day SMA is 1.21, which makes it a Buy.
- Aclaris Therapeutics 50-day simple moving average is 1.22 while ACRS share price is 1.22, making it a Sell technically.
- ACRS stock price is 1.22 and Aclaris Therapeutics 200-day simple moving average is 3.72, creating a Sell signal.
ACRS Technical Analysis vs Fundamental Analysis
Sell
11
Aclaris Therapeutics (ACRS)
is a Sell
Is Aclaris Therapeutics a Buy or a Sell?
-
Aclaris Therapeutics stock is rated a Sell
The current Aclaris Therapeutics [ACRS] share price is $1.22. The Score for ACRS is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
Aclaris Therapeutics Stock Info
Market Cap:
86.53M
Price in USD:
1.22
Share Volume:
633.43K
Aclaris Therapeutics 52-Week Range
52-Week High:
11.12
52-Week Low:
0.59
Sell
11
Aclaris Therapeutics (ACRS)
is a Sell
Aclaris Therapeutics Share Price Forecast
-
What is the Aclaris Therapeutics stock price today?
The Aclaris Therapeutics stock price is 1.22 USD today. -
Will ACRS stock go up or go down?
Aclaris Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Aclaris Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aclaris Therapeutics is overvalued.
Is Aclaris Therapeutics Stock a Buy?
- Aclaris Therapeutics share price is 1.22 while ACRS 8-day exponential moving average is 1.21, which is a Buy signal.
- The stock price of ACRS is 1.22 while Aclaris Therapeutics 20-day EMA is 1.21, which makes it a Buy.
- Aclaris Therapeutics 50-day exponential moving average is 1.25 while ACRS share price is 1.22, making it a Sell technically.
- ACRS stock price is 1.22 and Aclaris Therapeutics 200-day simple moving average is 3.60, creating a Sell signal.
Fundamental Analysis of Aclaris Therapeutics
Is Aclaris Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.06 per share, an increase this year of $0.55 per share, and an increase next year of $0.30 per share.
Technical Analysis of Aclaris Therapeutics
Should I short Aclaris Therapeutics stock?
- ACRS Moving Average Covergence Divergence (MACD) indicator is -0, suggesting Aclaris Therapeutics is a Sell
- Aclaris Therapeutics Relative Strength Index (RSI) is 51.41, which suggest Aclaris Therapeutics is overbought
- The Bollinger Bands (25) for Aclaris Therapeutics is (1.18 - 1.24), which suggest Aclaris Therapeutics is a Buy
- The Bollinger Bands (100) for Aclaris Therapeutics is (1.07 - 1.27), which suggest Aclaris Therapeutics is a Buy
* Aclaris Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.